Drawing from recent conversations with Australian healthcare innovators, including discussions at AusBiotech 2024, Dr. Peter Cronin explores the evolving challenges of US market entry. He shares insights on how companies are moving beyond traditional approaches to embrace data-driven, patient-centric strategies...